查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1996450

医用复合材料市场：2026-2032年全球市场预测（依树脂类型、纤维类型、製造流程、产品类型和最终用途产业划分）

Medical Composites Market by Resin Type, Fiber Type, Manufacturing Process, Product Type, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用复合材料市场价值将达到 19.1 亿美元，到 2026 年将成长到 22.5 亿美元，到 2032 年将达到 59.3 亿美元，复合年增长率为 17.51%。

主要市场统计数据
基准年 2025 19.1亿美元
预计年份：2026年 22.5亿美元
预测年份：2032年 59.3亿美元
复合年增长率 (%) 17.51%

清晰权威地概述了复合材料如何改变所有医疗保健环境中医疗设备的设计、製造和临床性能。

先进复合材料已成为实现下一代医疗设备和植入的关键要素，它兼具优异的机械性能、轻量化设计以及与临床工作流程的兼容性。过去十年间，聚合物化学、纤维技术和製程可重复性的进步克服了长期存在的临床和製造限制，使复合材料得以从小众应用领域走向主流产品架构。生物相容性热塑性塑胶、优化的纤维增强材料和精密製造技术的融合，在拓展医疗设备工程师设计自由度的同时，也满足了临床医生对可消毒、渗透性和抗疲劳组件的需求。

对加速医疗复合材料创新并重塑竞争格局的关键技术、监管和永续性变化进行清晰概述。

在技​​术进步、法规演变和跨领域知识转移的推动下，医用复合材料领域正经历变革。聚合物化学和纤维工程的创新使得以往难以实现的刚性、韧性和灭菌相容性组合成为可能。同时，积层製造和自动化层压系统降低了操作差异，并实现了针对患者优化的形态设计。此外，随着对永续发展和循环经济的日益重视，可回收热塑性塑胶和新型聚合物化学的研发也在不断推进，在不影响生物相容性的前提下降低了对环境的影响。这些并行发展的技术和环境趋势正在为供应商和原始设备製造商（OEM）创造新的竞争格局。

对 2025 年关税措施将如何重塑医疗复合材料整个价值链的筹资策略、供应商关係和製造重点进行可操作的分析。

2025年实施的新关税措施对整个医用复合材料生态系统产生了广泛而累积的影响，促使製造商和供应商进行供应链重组并采取策略性应对措施。面对某些原料和成品组件进口关税的提高，许多机构已重新审视筹资策略，以降低对单一国家的依赖。这加速了企业对供应商多元化、建立区域供应基地以及签订包含紧急条款和成本分摊机制的长期采购合约的兴趣。

全面的分析揭示了最终用途、树脂化学成分、纤维类型、製造流程、形状和产品类型如何相互作用并塑造战略重点。

细分市场层面的趋势凸显了最终用途、材料类型、纤维结构、製造流程、形态和产品类型等方面的机会与挑战的多样性。就最终用途产业的细分而言，应用领域涵盖航太和国防工业（包括机身、内装和机翼部件）、汽车工业（包括车身面板、底盘和内装部件）、医疗保健工业（包括医疗设备、整形外科植入和义肢）、船舶工业（包括甲板结构和船体）、运动休閒领域（包括自行车、高尔夫球桿和球拍）以及风力工业（包括甲板结构和船体）、运动休閒领域（包括自行车、高尔夫球桿和球拍）以及风力发电领域（包括风力机）和电轮发电领域。每种应用都需满足不同的性能、消毒和耐久性要求，这些要求会影响材料的选择和认证流程。

一份战略区域分析报告，概述了美洲、欧洲、中东和非洲以及亚太地区如何影响医用复合材料的采购、监管和製造选择。

区域趋势在塑造采购决策、监管流程和创新重点方面发挥着至关重要的作用。在美洲，成熟的医疗设备丛集、接近性主要医疗保健买家以及强调循证实践的法规环境，为高性能复合材料的应用创造了肥沃的土壤，这些应用需要快速的临床部署以及与供应商的密切合作。本土製造能力和工程人才储备支持近岸外包策略，随着企业努力降低受全球贸易波动的影响，近岸外包策略正蓬勃发展。

对树脂製造、纤维供应、加工、OEM 和服务供应商的公司如何透过技术、整合和监管合规能力实现差异化进行基于证据的评估。

医疗复合材料价值链上的主要企业正透过整合技术优势、供应链整合和监管专业知识来脱颖而出。专注于特种树脂研发的公司正投资于兼俱生物相容性、耐灭菌性和加工性能的树脂等级，而纤维製造商则在扩大其碳纤维和玻璃纤维的产能，以满足严格的医疗性能要求。复合材料加工商和契约製造正在提升自动化和测试能力，以降低多品种医疗项目的变异性并提高生产效率。

为行业领导者提供切实可行的建议，以加强供应链韧性、加快材料认证和实现製造营运现代化。

产业领导者应携手推进一系列战术性和策略倡议，在增强韧性的同时保持创新步伐。首先，应优先考虑供应链多元化，对不同地区的多个供应商进行认证，并为关键树脂和纤维储备紧急库存。同时，应加快材料认证计划，检验符合临床和灭菌要求的替代树脂和纤维组合，并减少对关税敏感型原料的依赖。

对调查方法进行透明的说明，概述了用于得出策略见解的综合性一级和二级研究方法、供应链映射和检验程序。

本摘要的研究采用了一种混合方法，整合了与关键相关人员的对话、技术文献综述和有针对性的供应链分析。主要数据包括对材料科学家、製造工程师、采购经理、法规遵循专家和临床最终用户的结构化访谈，以了解营运限制、性能优先顺序和合格障碍。除这些访谈外，还查阅了同行评审的工程文献、监管指导文件、专利申请以及阐述医疗应用材料和工艺要求的标准。

简洁地总结了材料创新、製造现代化和战略供应链决策如何决定医用复合材料的成功。

医用复合材料正处于转折点，材料创新、製造流程进步和政策趋势在此交汇，既带来风险也带来机会。由于该领域能够提供更轻、更强、更符合临床要求的解决方案，医疗设备设计的可能性正在不断扩大。同时，日益严格的监管和采购要求也对可追溯性和性能文件提出了更高的要求。贸易政策的变化和区域发展正在加速供应链的策略重组，推动企业投资多元化、近岸外包和供应商伙伴关係。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用复合材料市场：依树脂类型划分

  • 热塑性树脂
    • PEEK
      • 碳纤维增强
      • 无需填充
    • PP
      • 共聚物
      • 均聚物
    • PPS
      • 玻璃填充
      • 无需填充
  • 热固性树脂
    • 环氧树脂
      • 双酚A
      • 环烷基体系
      • 诺沃拉克
    • 聚酯纤维
      • DCPD
      • 间苯二甲酸
      • 邻苯二甲酸
    • 乙烯基酯
      • 阿特拉克
      • 德拉坎
      • 维奥瓦

第九章 医用复合材料市场：依纤维类型划分

  • 酰胺纤维
    • 间位芳香聚酰胺
    • 对位芳香聚酰胺
  • 碳纤维
    • PAN 类型
    • 音调系统
    • 人造丝
  • 玻璃纤维
    • C 玻璃
    • E玻璃
    • S玻璃

第十章 医用复合材料市场：依製造流程划分

  • 高压釜釜成型
  • 压缩成型
  • 缠绕成型
  • 手工积层
  • 普鲁
  • 树脂转注成形

第十一章 医用复合材料市场：依产品类型划分

  • 块状模塑胶
    • 导电BMC
    • 标准BMC
  • 缠绕成型产品
    • 管道和管材
    • 压力容器
  • 预孕
    • 碳预浸料
    • 玻璃预浸料
  • 拉挤型材
    • 角度
    • 频道
    • 工字钢
  • 片状成型塑料
    • Premium SMC
    • 标准SMC

第十二章 医用复合材料市场：依最终用途产业划分

  • 航太/国防
    • 机身部件
    • 内部零件
    • 主翼部件
  • 车
    • 车身面板
    • 底盘部件
    • 内部零件
  • 卫生保健
    • 医疗设备
    • 整形外科植入
    • 义肢
  • 船
    • 甲板结构
    • 船体
  • 运动休閒
    • 自行车
    • 高尔夫俱乐部
    • 球拍
  • 风力
    • 刀刃
    • 中心
    • 纳赛尔

第十三章 医用复合材料市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医用复合材料市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 医用复合材料市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医用复合材料市场

第十七章：中国医用复合材料市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • ACP Composites, Inc.
  • Arkema SA
  • Avient Corporation
  • Celanese Corporation
  • Composiflex Corporation
  • Dentsply Sirona Inc.
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Koninklijke DSM NV
  • Mitsubishi Chemical Corporation
  • Royal DSM NV
  • Saudi Basic Industries Corporation
  • SGL Carbon SE
  • Solvay SA
  • Teijin Limited
  • Victrex plc
Product Code: MRR-FD3F12D52D24

The Medical Composites Market was valued at USD 1.91 billion in 2025 and is projected to grow to USD 2.25 billion in 2026, with a CAGR of 17.51%, reaching USD 5.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.91 billion
Estimated Year [2026] USD 2.25 billion
Forecast Year [2032] USD 5.93 billion
CAGR (%) 17.51%

A clear and authoritative introduction explaining how composite materials are reshaping medical device design, manufacturing, and clinical performance across care environments

Advanced composite materials have emerged as a pivotal enabler of next-generation medical devices and implants, combining mechanical performance, lightweight design, and compatibility with clinical workflows. Over the past decade, composites have migrated from niche applications into mainstream product architectures due to improvements in polymer chemistry, fiber technology, and process repeatability that together address longstanding clinical and manufacturing constraints. The convergence of biocompatible thermoplastics, tailored fiber reinforcements, and precision manufacturing has expanded design freedom for device engineers while responding to clinician demands for sterilizable, radiolucent, and fatigue-resistant components.

Clinical adoption is further supported by procedural shifts toward minimally invasive techniques and implant designs that require high strength-to-weight ratios and modularity. In parallel, healthcare procurement and hospital technology assessment groups are increasingly evaluating lifecycle performance and serviceability, elevating the importance of durable composite solutions. These dynamics compel device manufacturers, materials suppliers, and contract manufacturers to coordinate closely on material selection, process validation, and regulatory documentation. Consequently, medical composites are not merely a materials choice but a systems-level decision that influences manufacturing footprints, supply chain architecture, and the speed with which new devices can be introduced into highly regulated markets.

An incisive overview of the major technological, regulatory, and sustainability shifts that are accelerating innovation and altering competitive dynamics in medical composites

The landscape for medical composites is in the midst of transformative shifts driven by technological progress, regulatory evolution, and cross-sector knowledge transfer. Innovations in resin chemistry and fiber engineering are enabling combinations of stiffness, toughness, and sterilization compatibility previously unattainable, while additive manufacturing and automated lay-up systems are reducing labor variability and enabling patient-specific geometries. At the same time, greater emphasis on sustainability and circularity is prompting development of recyclable thermoplastics and novel resin chemistries that reduce environmental impact without compromising biocompatibility. These parallel technical and environmental trends are creating a new competitive axis for suppliers and OEMs.

Regulatory frameworks are also evolving to accommodate complex, multi-material devices. Regulators are increasingly focused on material traceability, sterilization validation, and long-term performance data, which in turn affects qualification timelines and documentation requirements. Moreover, lessons learned from aerospace and automotive sectors-especially in quality systems, nondestructive testing, and supply chain audits-are being adapted to medical contexts, accelerating maturity in manufacturing and certification practices. Together, these shifts are redefining how product roadmaps are constructed, which partnerships are prioritized, and how capital is deployed to scale manufacturing while maintaining compliance and patient safety.

A practical analysis of how 2025 tariff measures have reshaped sourcing strategies, supplier relationships, and manufacturing priorities across the medical composites value chain

The introduction of new tariff measures in the United States in 2025 has exerted a broad and cumulative influence across the medical composites ecosystem, prompting supply chain realignments and strategic responses from manufacturers and suppliers. Faced with higher import duties on certain raw materials and finished components, many organizations have reassessed sourcing strategies to reduce exposure to single-country dependencies. This has accelerated interest in supplier diversification, regional supply bases, and long-term procurement agreements that incorporate contingency provisions and cost-sharing mechanisms.

At a product level, tariffs have increased the relative attractiveness of domestically produced resins and fibers, incentivizing investments in local compounding, fiber conversion, and prepreg production. Procurement teams within medical device companies have become more proactive in qualifying alternative materials and negotiating lead times to smooth production continuity. In parallel, contract manufacturers and converters have sought to mitigate margin pressure through process optimization, yield improvement, and selective price adjustments, while also engaging in design reviews to identify opportunities for material substitution where clinically appropriate.

Policy-driven cost pressures have also spurred nearshoring conversations, with stakeholders weighing the trade-offs between labor cost, regulatory proximity, and supply reliability. Importantly, tariffs have acted as a catalyst for upstream partnerships between resin producers and device OEMs, accelerating joint development of resin grades that reduce dependence on tariff-affected inputs. Together, these responses are shifting capital allocation toward flexibility and resilience, even as organizations seek to preserve product performance and compliance.

Comprehensive segmentation insights that reveal how end use, resin chemistries, fiber classes, manufacturing routes, form factors, and product types interact to shape strategic priorities

Segment-level dynamics underscore the heterogeneity of opportunities and challenges across end uses, material types, fiber architectures, manufacturing processes, form factors, and product categories. When considering end use industry segmentation, applications span Aerospace & Defense with fuselage, interior, and wing components; Automotive with body panel, chassis, and interior components; Healthcare with medical devices, orthopedic implants, and prosthetics; Marine with deck structures and hulls; Sports & Leisure with bicycles, golf clubs, and rackets; and Wind Energy with blades, hubs, and nacelles. Each application imposes different performance, sterilization, and longevity requirements that influence material selection and qualification pathways.

Resin type segmentation further illuminates development trajectories. Thermoplastic classes, including PEEK, PP, and PPS, are gaining traction for their reprocessability and sterilization profiles; within PEEK the distinction between carbon fiber reinforced and unfilled grades affects stiffness and radiolucency, while PP copolymer and homopolymer grades balance cost and ductility and PPS glass-filled options deliver temperature and chemical resistance. Thermoset families such as epoxy, polyester, and vinyl ester remain important where high-temperature cure and specific mechanical properties are required; epoxy variants like Bisphenol-A, cycloaliphatic, and novolac offer different trade-offs in toughness and thermal stability, while polyester grades including DCPD, isophthalic, and orthophthalic serve cost-sensitive structural roles, and vinyl ester chemistries such as Atlac, Derakane, and Veova provide corrosion resistance.

Fiber type segmentation informs mechanical design and cost dynamics, with aramid fibers split into meta-aramid and para-aramid options for impact resistance and cut resistance, carbon fiber classes of PAN-based, pitch-based, and rayon-based providing varying stiffness and weight characteristics, and glass fiber types like C-Glass, E-Glass, and S-Glass offering scalable strength at competitive cost. Manufacturing process segmentation across autoclave molding, compression molding, filament winding, hand lay-up, pultrusion, and resin transfer molding introduces distinct constraints on part geometry, cycle time, and quality assurance protocols that influence unit economics and qualification timelines. Form factor considerations include pipes and tubes, profiles and others that encompass fabrics and nonwoven mats, rods and bars, and sheets and plates, each dictating downstream processing and finishing steps. Product type segmentation spans bulk molding compound in conductive and standard variants, filament wound products comprising pipes and tubes and pressure vessels, prepregs divided into carbon and glass types, pultruded profiles such as angles, channels, and I-beams, and sheet molding compound in premium and standard tiers.

Taken together, these layered segments create a matrix of technical requirements, supply risks, and commercial opportunities. Transitioning from one segment to another often requires adjustments in supplier qualification, validation protocols, and manufacturing controls. For example, a shift from hand lay-up to automated filament winding will necessitate investments in tooling, nondestructive inspection, and process monitoring. Similarly, moving from thermoset prepreg to thermoplastic solutions can unlock recycling benefits but requires retooling and requalification for sterilization compatibility. Understanding these interdependencies enables product teams to make deliberate trade-offs between performance, cost, and time to market.

A strategic regional analysis outlining how the Americas, Europe Middle East & Africa, and Asia-Pacific each influence sourcing, regulation, and manufacturing choices for medical composites

Regional dynamics play a decisive role in shaping sourcing decisions, regulatory pathways, and innovation priorities. In the Americas, the combination of established medical device clusters, proximity to major healthcare purchasers, and a regulatory environment oriented toward evidentiary rigor creates fertile ground for high-performance composite applications that demand rapid clinical adoption and close supplier collaboration. Domestic manufacturing capabilities and engineering talent pools support nearshoring strategies, which have gained momentum as organizations seek to reduce exposure to global trade volatility.

Europe, Middle East & Africa features a diverse industrial base and a regulatory landscape that emphasizes device lifecycle surveillance and traceability. The EU medical device regulatory framework and regional standards influence material qualification and post-market obligations, prompting manufacturers to invest in more comprehensive testing and documentation. Additionally, strong aerospace and wind energy clusters in parts of Europe encourage cross-pollination of advanced composite manufacturing techniques, while regional sustainability targets drive demand for recyclable and lower-emission production approaches.

Asia-Pacific offers scale and cost-competitive manufacturing capacity across several jurisdictions, with significant investments in fiber and resin production as well as composite conversion. Rapidly growing healthcare demand in parts of the region is increasing local adoption of advanced devices, and government incentives in manufacturing and technology development are accelerating capacity expansion. However, variability in regulatory maturity and supply chain transparency requires buyers to adopt rigorous qualification practices when sourcing from multiple countries within the region. Collectively, these regional attributes influence strategic decisions around supplier selection, inventory strategies, and investment in localized capabilities.

An evidence-driven assessment of how firms across resin production, fiber supply, conversion, OEMs, and service providers are differentiating through technology, integration, and regulatory capabilities

Leading organizations in the medical composites value chain are differentiating through a combination of technical excellence, supply chain integration, and regulatory expertise. Companies that focus on specialty resin development are investing in grades that balance biocompatibility, sterilization tolerance, and processability, while fiber producers are expanding capacities for carbon and glass variants that meet stringent medical performance requirements. Composite converters and contract manufacturers are scaling automation and inspection capabilities to reduce variability and raise throughput for high-mix medical programs.

Medical device OEMs are increasingly forming strategic alliances with materials suppliers to accelerate product-specific qualification and to de-risk long lead-time inputs. This trend is accompanied by deeper investment in in-house regulatory affairs and materials science teams, enabling faster translation from materials selection to clinical validation. Service providers, including testing laboratories and sterilization specialists, are expanding offerings to include accelerated aging, biocompatibility studies, and comprehensive nondestructive testing suites tailored to composite architectures.

Additionally, successful companies are prioritizing sustainability initiatives such as lifecycle assessments and recyclable material systems, recognizing that healthcare procurement officers are placing greater emphasis on environmental impact. M&A and joint development agreements are being leveraged to acquire niche capabilities, secure local supply, or access regulatory documentation, while operational leaders are investing in workforce development to bridge the skills gap in composite-specific manufacturing and quality assurance.

Actionable and practical recommendations that industry leaders can implement to enhance supply chain resilience, accelerate material qualification, and modernize manufacturing operations

Industry leaders should pursue a coordinated set of tactical and strategic actions that strengthen resilience while preserving innovation velocity. First, prioritize supply chain diversification by qualifying multiple suppliers across different regions and by establishing contingency inventory buffers for critical resins and fibers. Simultaneously, accelerate material qualification programs that validate alternative resin and fiber combinations capable of meeting clinical and sterilization requirements, thereby reducing dependency on tariff-exposed inputs.

Second, invest in manufacturing modernization to lower unit variability and improve yield, focusing on automation, inline inspection, and digital traceability. These investments shorten qualification cycles and improve reproducibility across production sites. Third, embed regulatory strategy early in product development, engaging with regulatory authorities through pre-submission consultations and maintaining robust material and process documentation to smooth approval pathways. Fourth, develop circularity strategies that include recyclable thermoplastics, design for disassembly, and validated sterilization-compatible reuse where clinically appropriate, aligning product portfolios with procurement and sustainability priorities.

Fifth, pursue collaborative models with material suppliers, contract manufacturers, and clinical partners to share risk and accelerate time to clinical adoption, while exploring co-investment in local production facilities where nearshoring delivers strategic value. Finally, invest in workforce skills and change management to ensure teams can operate new manufacturing technologies and maintain compliance, thereby translating technical investments into reliable production and market access.

A transparent methodological statement describing the integrated primary and secondary research approach, supply chain mapping, and validation steps used to derive strategic insights

The research underpinning this summary was developed using a mixed-methods approach that integrates primary stakeholder engagement, technical literature review, and targeted supply chain analysis. Primary inputs included structured interviews with materials scientists, manufacturing engineers, procurement leaders, regulatory affairs specialists, and clinical end users to capture operational constraints, performance priorities, and qualification hurdles. These interviews were complemented by reviews of peer-reviewed engineering literature, regulatory guidance documents, patent filings, and standards that inform material and process expectations in medical applications.

Supply chain mapping exercises identified key nodes for raw material conversion, prepreg and composite fabrication, and final assembly, enabling analysis of lead-time vulnerabilities and concentration risks. Technology assessments evaluated the readiness levels of thermoplastic and thermoset systems, fiber classes, and automated manufacturing platforms, while case studies highlighted successful qualification and manufacturing scale-up pathways. Findings were iteratively validated through expert workshops and cross-functional review to ensure practical applicability. Methodological limitations include variability in proprietary qualification standards across organizations and evolving policy environments; where appropriate, conservative language was used to reflect areas of uncertainty.

A concise conclusion that synthesizes how material innovation, manufacturing modernization, and strategic supply chain decisions will determine success in medical composites

Medical composites are at an inflection point where material innovation, manufacturing evolution, and policy dynamics converge to create both risk and opportunity. The sector's ability to deliver lighter, stronger, and clinically compatible solutions is expanding the universe of possible device designs, while regulatory and procurement expectations demand higher levels of traceability and performance documentation. Trade policy shifts and regional dynamics are accelerating strategic realignment of supply chains, prompting investments in diversification, nearshoring, and supplier partnerships.

To navigate this environment, organizations must adopt an integrated approach that aligns materials science, process engineering, regulatory strategy, and commercial planning. Companies that proactively qualify resilient material supply chains, modernize manufacturing with automation and inspection, and engage regulators early will be best positioned to translate composite advantages into durable clinical and commercial success. Collaboration across the value chain-between resin suppliers, fiber producers, converters, OEMs, and clinical partners-will be essential to unlock scale and manage risk as the industry matures.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Composites Market, by Resin Type

  • 8.1. Thermoplastic
    • 8.1.1. PEEK
      • 8.1.1.1. Carbon Fiber Reinforced
      • 8.1.1.2. Unfilled
    • 8.1.2. PP
      • 8.1.2.1. Copolymer
      • 8.1.2.2. Homopolymer
    • 8.1.3. PPS
      • 8.1.3.1. Glass Filled
      • 8.1.3.2. Unfilled
  • 8.2. Thermoset
    • 8.2.1. Epoxy
      • 8.2.1.1. Bisphenol-A
      • 8.2.1.2. Cycloaliphatic
      • 8.2.1.3. Novolac
    • 8.2.2. Polyester
      • 8.2.2.1. DCPD
      • 8.2.2.2. Isophthalic
      • 8.2.2.3. Orthophthalic
    • 8.2.3. Vinyl Ester
      • 8.2.3.1. Atlac
      • 8.2.3.2. Derakane
      • 8.2.3.3. Veova

9. Medical Composites Market, by Fiber Type

  • 9.1. Aramid Fiber
    • 9.1.1. Meta-Aramid
    • 9.1.2. Para-Aramid
  • 9.2. Carbon Fiber
    • 9.2.1. PAN-Based
    • 9.2.2. Pitch-Based
    • 9.2.3. Rayon-Based
  • 9.3. Glass Fiber
    • 9.3.1. C-Glass
    • 9.3.2. E-Glass
    • 9.3.3. S-Glass

10. Medical Composites Market, by Manufacturing Process

  • 10.1. Autoclave Molding
  • 10.2. Compression Molding
  • 10.3. Filament Winding
  • 10.4. Hand Lay-Up
  • 10.5. Pultrusion
  • 10.6. Resin Transfer Molding

11. Medical Composites Market, by Product Type

  • 11.1. Bulk Molding Compound
    • 11.1.1. Conductive BMC
    • 11.1.2. Standard BMC
  • 11.2. Filament Wound Products
    • 11.2.1. Pipes & Tubes
    • 11.2.2. Pressure Vessels
  • 11.3. Prepreg
    • 11.3.1. Carbon Prepreg
    • 11.3.2. Glass Prepreg
  • 11.4. Pultruded Profiles
    • 11.4.1. Angles
    • 11.4.2. Channels
    • 11.4.3. I-Beams
  • 11.5. Sheet Molding Compound
    • 11.5.1. Premium SMC
    • 11.5.2. Standard SMC

12. Medical Composites Market, by End Use Industry

  • 12.1. Aerospace & Defense
    • 12.1.1. Fuselage Components
    • 12.1.2. Interior Components
    • 12.1.3. Wing Components
  • 12.2. Automotive
    • 12.2.1. Body Panel
    • 12.2.2. Chassis Components
    • 12.2.3. Interior Components
  • 12.3. Healthcare
    • 12.3.1. Medical Devices
    • 12.3.2. Orthopedic Implants
    • 12.3.3. Prosthetics
  • 12.4. Marine
    • 12.4.1. Deck Structures
    • 12.4.2. Hulls
  • 12.5. Sports & Leisure
    • 12.5.1. Bicycles
    • 12.5.2. Golf Clubs
    • 12.5.3. Rackets
  • 12.6. Wind Energy
    • 12.6.1. Blades
    • 12.6.2. Hubs
    • 12.6.3. Nacelles

13. Medical Composites Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Composites Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Composites Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Composites Market

17. China Medical Composites Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. ACP Composites, Inc.
  • 18.7. Arkema S.A.
  • 18.8. Avient Corporation
  • 18.9. Celanese Corporation
  • 18.10. Composiflex Corporation
  • 18.11. Dentsply Sirona Inc.
  • 18.12. DuPont de Nemours, Inc.
  • 18.13. Evonik Industries AG
  • 18.14. Koninklijke DSM N.V.
  • 18.15. Mitsubishi Chemical Corporation
  • 18.16. Royal DSM N.V.
  • 18.17. Saudi Basic Industries Corporation
  • 18.18. SGL Carbon SE
  • 18.19. Solvay SA
  • 18.20. Teijin Limited
  • 18.21. Victrex plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL COMPOSITES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL COMPOSITES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL COMPOSITES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL COMPOSITES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL COMPOSITES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL COMPOSITES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER REINFORCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COPOLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HOMOPOLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY UNFILLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BISPHENOL-A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CYCLOALIPHATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NOVOLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DCPD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ISOPHTHALIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPHTHALIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ATLAC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DERAKANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY VEOVA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY META-ARAMID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PARA-ARAMID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PAN-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PAN-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PAN-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PITCH-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PITCH-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PITCH-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RAYON-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RAYON-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RAYON-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY C-GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY C-GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY C-GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY E-GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY E-GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY E-GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY S-GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY S-GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY S-GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOCLAVE MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOCLAVE MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOCLAVE MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COMPRESSION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COMPRESSION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY COMPRESSION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WINDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WINDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WINDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HAND LAY-UP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HAND LAY-UP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HAND LAY-UP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TRANSFER MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TRANSFER MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RESIN TRANSFER MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CONDUCTIVE BMC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CONDUCTIVE BMC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CONDUCTIVE BMC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD BMC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD BMC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD BMC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PIPES & TUBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PIPES & TUBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PIPES & TUBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRESSURE VESSELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRESSURE VESSELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PRESSURE VESSELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON PREPREG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON PREPREG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CARBON PREPREG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS PREPREG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS PREPREG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GLASS PREPREG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ANGLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ANGLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ANGLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY I-BEAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY I-BEAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY I-BEAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREMIUM SMC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREMIUM SMC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PREMIUM SMC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD SMC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD SMC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY STANDARD SMC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY FUSELAGE COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WING COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BODY PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY CHASSIS COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY INTERIOR COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY PROSTHETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY MARINE, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY DECK STRUCTURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HULLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BICYCLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY GOLF CLUBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY RACKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY BLADES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY HUBS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY NACELLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL MEDICAL COMPOSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 267. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 268. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2018-2032 (USD MILLION)
  • TABLE 270. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2018-2032 (USD MILLION)
  • TABLE 271. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PP, 2018-2032 (USD MILLION)
  • TABLE 272. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2018-2032 (USD MILLION)
  • TABLE 273. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2018-2032 (USD MILLION)
  • TABLE 274. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
  • TABLE 275. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2018-2032 (USD MILLION)
  • TABLE 276. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, 2018-2032 (USD MILLION)
  • TABLE 277. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, 2018-2032 (USD MILLION)
  • TABLE 279. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, 2018-2032 (USD MILLION)
  • TABLE 280. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, 2018-2032 (USD MILLION)
  • TABLE 281. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 282. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 284. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 285. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, 2018-2032 (USD MILLION)
  • TABLE 286. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, 2018-2032 (USD MILLION)
  • TABLE 287. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 288. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 289. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 290. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
  • TABLE 291. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 292. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY MARINE, 2018-2032 (USD MILLION)
  • TABLE 293. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, 2018-2032 (USD MILLION)
  • TABLE 294. AMERICAS MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, 2018-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 296. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2018-2032 (USD MILLION)
  • TABLE 298. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2018-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PP, 2018-2032 (USD MILLION)
  • TABLE 300. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2018-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2018-2032 (USD MILLION)
  • TABLE 302. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2018-2032 (USD MILLION)
  • TABLE 304. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY VINYL ESTER, 2018-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY FIBER TYPE, 2018-2032 (USD MILLION)
  • TABLE 306. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY ARAMID FIBER, 2018-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY CARBON FIBER, 2018-2032 (USD MILLION)
  • TABLE 308. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY GLASS FIBER, 2018-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY MANUFACTURING PROCESS, 2018-2032 (USD MILLION)
  • TABLE 310. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY BULK MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 312. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY FILAMENT WOUND PRODUCTS, 2018-2032 (USD MILLION)
  • TABLE 313. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PREPREG, 2018-2032 (USD MILLION)
  • TABLE 314. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PULTRUDED PROFILES, 2018-2032 (USD MILLION)
  • TABLE 315. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY SHEET MOLDING COMPOUND, 2018-2032 (USD MILLION)
  • TABLE 316. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 317. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY AEROSPACE & DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 318. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY AUTOMOTIVE, 2018-2032 (USD MILLION)
  • TABLE 319. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 320. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY MARINE, 2018-2032 (USD MILLION)
  • TABLE 321. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY SPORTS & LEISURE, 2018-2032 (USD MILLION)
  • TABLE 322. NORTH AMERICA MEDICAL COMPOSITES MARKET SIZE, BY WIND ENERGY, 2018-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 324. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY RESIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY THERMOPLASTIC, 2018-2032 (USD MILLION)
  • TABLE 326. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PEEK, 2018-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PP, 2018-2032 (USD MILLION)
  • TABLE 328. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY PPS, 2018-2032 (USD MILLION)
  • TABLE 329. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY THERMOSET, 2018-2032 (USD MILLION)
  • TABLE 330. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY EPOXY, 2018-2032 (USD MILLION)
  • TABLE 331. LATIN AMERICA MEDICAL COMPOSITES MARKET SIZE, BY POLYESTER, 2018-2032 (USD MILLION)
  • TABLE 332. LATIN AMERICA MEDICAL COM